Key result
Genomic analysis of CVA2 strains identifies a novel C5 lineage with potential CVA10 recombination.
Why the study?
Increasing CVA2 incidence and limited full-length genomes motivated complete genome sequence analysis to understand its molecular epidemiology and evolutionary dynamics.
Observational (n=19)
The identification of a novel CVA2 lineage with specific mutations and recombination events provides insight into the evolutionary epidemiology and emergence of the virus in Thailand.
Novel CVA2 C5 lineage detection supports enterovirus surveillance in Thailand; leaves open clinical impact of recombination and mutations.
Coxsackievirus A2 (CVA2), a member of enterovirus A species (EV-A), is associated with diverse human diseases and occasionally causes acute gastroenteritis (AGE). In Thailand, CVA2 emerged as the predominant genotype in 2019. The increasing incidence of CVA2, coupled with the limited availability of full-length genomes, highlights the need for more complete genome sequence analysis to facilitate molecular epidemiology study. This study aimed to investigate the molecular epidemiology, evolutionary dynamics, and recombination characteristics of CVA2 associated with AGE in Thailand from 2013 to 2022. A total of 19 full-genome sequences of CVA2 isolated from stool samples of AGE patients in Thailand were characterized and analyzed together with the reference sequences available in the GenBank database. A novel lineage of CVA2 (subgenotype C5) was detected with the potential recombination with CVA10 within the P2 and P3 regions. Specific consensus amino acid mutations, A61S in the VP3 gene and R136K in the 3D (RdRp) gene, were identified in all CVA2 recombinant strains. Additionally, the S45G mutation in the RdRp gene was found to be potentially associated with the emergence of CVA2 infection in 2019. In conclusion, this study reveals potential intertypic recombinant events and specific mutations in CVA2 strains isolated from AGE patients and provides a broader understanding of its evolutionary epidemiology.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2024) conducted an observational in Acute gastroenteritis (AGE) (n=19). Coxsackievirus A2 (CVA2) infection was evaluated on Molecular epidemiology, evolutionary dynamics, and recombination characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: